N-acetylserotonin, melatonin and their derivatives improve cognition and protect against β-amyloid-induced neurotoxicity

Annals of the New York Academy of Sciences

Volumn 890, Issue , 1999, Pages 155-166

  Bachurin, S ^a,b   Oxenkrug, G F ^a,b   Lermontova, N ^a,b   Afanasiev, A ^a,b   Beznosko, B ^a,b   Vankin, G ^a,b   Shevtzova, E ^a,b   Mukhina, T ^a,b   Serkova, T ^a,b  

^a INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CA 15; CA 18; ETHYLCHOLINE MUSTARD AZIRIDINIUM; MELATONIN; MELATONIN DERIVATIVE; N ACETYLSEROTONIN; NEUROPROTECTIVE AGENT; NEUROTOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AVOIDANCE BEHAVIOR; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; GRANULE CELL; LEARNING; MALE; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; SEDATION;

ANIMALIA;

EID: 0033400740     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07990.x     Document Type: Conference Paper

References (24)

1. 1. Witting, W., I. Kwa, P. Eikelenboom, M. Mirmiram & D. Swaab. 1990. Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol. Psychiatry 27: 563-572.
2. 2. Reiter, R.J., M.I. Pablos, T.T. Agapito & J.M. Guerrero. 1996. Melatonin in the context of the free radical theory of aging. Ann. N.Y. Acad. Sci. 786: 362-378.
3. 3. Papolla, M.A., M. Sos, R.A. Omar, d. Bick, L.M. Hicksonbick, R.J. Reiter, S. Epthimiopoulus & N.K. Robakis. 1997. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17: 1683-1690.
4. 4. Longoni, B., W.A. Pryor & P. Marchiafava. 1997. Inhibition of lipid peroxidation by N-acetylserotonin and its role in retinal physiology. Biochem. Biophys. Res. Commun. 233: 778-780.
5. 5. Fisher, A. & I. Hanin. 1986. Potential animal models for senile dementia of Alzheimer's type with emphasis on AF64A-induced cholinotoxicity. Annu. Rev. Pharmacol. Toxicol. 26: 161-181.
6. 6. Walsh, T. & K. Opello. 1994. The use of AF64A to model Alzheimer disease. In Toxin-Induced Models of Neurological Disorders. M.I. Woodruff & A.J. Nonneman, Eds.: 259-279. Plenum Press. New York, London.
7. 7. Lermontova, N.N., N.V. Lukoyanov, T.P. Serkova, E.A. Lykoyanova & S.O. Bachurin. 1998. Effects of tacrine on memory deficits in rats treated with cholinergic neurotoxin AF64A. Mol. Chem. Neuropathol. 33: 51-61.
8. 8. Gozes, I., A. Bardea, A. Reshef, R. Zamostiano, S. Zhukovsky, S. Rubinraut, M. Fridkin & D. Brenneman. 1996. Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. Proc. Natl. Acad. Sci. USA 93: 427-432.
9. 9. Gallo, V., A. Kingsbury, R. Balazs & O.S. Jorgensen. 1987. The role of depolarisation in the survival and differentiation of cerebellar granule cells in culture. J. Neurosci. 7: 2203-2213.
10. 10. Bachurin, S., N. Lermontova, E. Shevtzova, T. Serkova & E. Kireeva. 1998. Prevention of β-amyloid-induced neurotoxicity by tacrine and dimebon. J. Neurochem. 71(Suppl. 1): S68.
11. 11. Gulyaeva, N.V., N.A. Lazareva & N.L. Libe. 1996. Oxidative stress in the brain following intraventricular administration of ethylholine aziridinium (AF64A). Brain Res. 726: 174-180.
12. 12. Barsacchi, R., C. Kusmic, E. Damiani, P. Carloni, L. Greci & L. Donato. 1998. Vitamin E consumption induced by oxidative stress in red blood cells is enhanced by melatonin and reduced by N-acetylserotonin. Free Radical Biol. Med. 24: 1187-1192.
13. 13. Satake, N. & B.E. Morton. 1979. Scotophobin A causes dark avoidance in goldfish by elevating pineal N-acetylserotonin. Pharmacol. Biochem. Behav. 10: 449-436.
14. 14. Morton, D.J. 1987. Both hydroxy-and methoxyindoles modify basal temperature in the rat. J. Pineal Res. 4: 1-5.
15. 15. Psarakis, S., G. Brown & L.J. Grota. 1988. Analgesia induced by N-acetyl-serotonin in the central nervous system. Life Sci. 42: 1109-1116.
16. 16. Oxenkrug, G.F. 1998. N-Acetylserotonin and the hypotensive effect of MAO-A inhibition (mini-review). Vopr. Med. Khim. 43: 522-526 (Russian).
17. 17. Oxenkrug, G.F. 1999. Antidepressive and antihypertensive effects of MAO-A inhibition: role of N-acetylserotonin. A review. J. Neurobiol. 7: 213-224.
18. 18. Oxenkrug, G.F. & P.J. Requintina. 1999. Hypotensive effect of N-acetylserotonin in spontaneously hypertensive rats. Biol. Psychiatry. In press.
19. ++ antagonist, on activity of MAO inhibitors, N-acetylserotonin and melatonin in the mouse tail suspension test. Int. J. Neuropsychopharmacol. 1: 35-40.
20. 20. Lezoualc'h, F., M. Sparapani & C. Behl. 1998. N-Acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-κB. J. Pineal Res. 24: 168-178.
21. 21. Leone, R.M. & R.E. Silman. 1984. Melatonin can be differentially metabolized in the rat to produce N-acetyl-serotonin in addition to 6-hydroxy-melatonin. Endocrinology 114: 1825-1832.
22. 22. Duell, P.B,. D.L. Wheaton, A. Shultz & H. Nguyen. 1998. Inhibition of LDL oxidation by melatonin requires supraphysiologic concentrations. Clin. Chem. 44: 1931-1936.
23. 23. Oxenkrug, G.F. & P.J. Requintina. 1994. Stimulation of rat pineal melatonin biosynthesis by N-acetylserotonin. Int. J. Neurosci. 77: 237-241.
24. 24. Oxenkrug, G.F., S.O. Bachurin, I.V. Prakhie, P.J. Requintina, A. Afanasiev, B. Beznosko, G. Vankin, N. Lermontova & T. Serkova. 1999. Neurobiological effects of the new indolalkylamine derivatives. Biol. Psychiatry 45: 92S.